Special Issue on Molecular and Translational Research on Colorectal Cancer 2.0 by Alessandro Passardi, Emanuela Scarpi, Paola Ulivi

Get full text

Molecular and Translational Research on Colorectal Cancer by Alessandro Passardi, Emanuela Scarpi, Paola Ulivi

Get full text

Metastatic Colorectal Cancer by Alessandro Passardi, Giorgia Marisi, Paola Ulivi

Get full text

Editorial: Molecular targets for the treatment of metastatic colorectal cancer by Alessandro Passardi, David Gibbons, David Gibbons

Get full text

Towards Personalized Treatment and Molecular Research on Gastrointestinal Tumors by Alessandro Passardi, Emanuela Scarpi, Paola Ulivi

Get full text

Editorial: Identification of novel biomarkers for pancreatic and hepatocellular cancers by Laura Matteucci, Ilario Giovanni Rapposelli, Alessandro Passardi

Get full text

Immunocheckpoint Inhibitors in Microsatellite-Stable or Proficient Mismatch Repair Metastatic Colorectal Cancer: Are We Entering a New Era? by Laura Matteucci, Alessandro Bittoni, Graziana Gallo, Laura Ridolfi, Alessandro Passardi

Get full text

Gemcitabine, a rare cause of chemotherapy-related reticulate hyperpigmentation by Francesco Savoia, Matelda Medri, Alessandro Passardi, Davide Melandri, Ignazio Stanganelli

Get full text

Editorial: Angiogenesis blockade for the treatment of gastrointestinal cancer by Alessandro Passardi, Alessandro Bittoni, Zhigang Bai, Zhongtao Zhang, Cornelis Sier, Yulong He, Endrit Shahini, Antonio Giovanni Solimando

Get full text

Instability of Non-Standard Microsatellites in Relation to Prognosis in Metastatic Colorectal Cancer Patients by Francesca Pirini, Luigi Pasini, Gianluca Tedaldi, Emanuela Scarpi, Giorgia Marisi, Chiara Molinari, Daniele Calistri, Alessandro Passardi, Paola Ulivi

Get full text

Circulating Plasma Levels of miR-20b, miR-29b and miR-155 as Predictors of Bevacizumab Efficacy in Patients with Metastatic Colorectal Cancer by Paola Ulivi, Matteo Canale, Alessandro Passardi, Giorgia Marisi, Martina Valgiusti, Giovanni Luca Frassineti, Daniele Calistri, Dino Amadori, Emanuela Scarpi

Get full text

Equivalent Efficacy but Different Safety Profiles of Gemcitabine Plus Nab-Paclitaxel and FOLFIRINOX in Metastatic Pancreatic Cancer by Ilario Giovanni Rapposelli, Andrea Casadei-Gardini, Caterina Vivaldi, Giulia Bartolini, Laura Bernardini, Alessandro Passardi, Giovanni Luca Frassineti, Valentina Massa, Alessandro Cucchetti

Get full text

Circulating VEGF and eNOS variations as predictors of outcome in metastatic colorectal cancer patients receiving bevacizumab by Giorgia Marisi, Emanuela Scarpi, Alessandro Passardi, Oriana Nanni, Angela Ragazzini, Martina Valgiusti, Andrea Casadei Gardini, Luca Maria Neri, Giovanni Luca Frassineti, Dino Amadori, Paola Ulivi

Get full text

Cytoreduction plus hyperthermic intraperitoneal chemotherapy for peritoneal carcinomatosis in colorectal cancer patients: a single-center cohort study by Leonardo Solaini, Fabrizio D’Acapito, Alessandro Passardi, Massimo Framarini, Francesca Tauceri, Daniela Di Pietrantonio, Giovanni Luca Frassineti, Andrea Casadei Gardini, Alessandro Cucchetti, Davide Cavaliere, Giorgio Ercolani

Get full text

Association between Pre-Treatment Biological Indicators and Compliance to Neoadjuvant/Perioperative Chemotherapy in Operable Gastric Cancer by Manlio Monti, Andrea Prochowski Iamurri, David Bianchini, Chiara Gallio, Luca Esposito, Daniela Montanari, Silvia Ruscelli, Chiara Molinari, Flavia Foca, Alessandro Passardi, Giovanni Vittimberga, Paolo Morgagni, Giovanni Luca Frassineti

Get full text

A Remote Monitoring System to Optimize the Home Management of Oral Anticancer Therapies (ONCO-TreC): Prospective Training–Validation Trial by Alessandro Passardi, Flavia Foca, Orazio Caffo, Carlo Alberto Tondini, Alberto Zambelli, Roberto Vespignani, Giulia Bartolini, Francesco Giulio Sullo, Daniele Andreis, Marco Dianti, Claudio Eccher, Enrico Maria Piras, Stefano Forti

Get full text

An Integrated Model to Improve Medication Reconciliation in Oncology: Prospective Interventional Study by Alessandro Passardi, Patrizia Serra, Caterina Donati, Federica Fiori, Sabrina Prati, Roberto Vespignani, Gabriele Taglioni, Patrizia Farfaneti Ghetti, Giovanni Martinelli, Oriana Nanni, Mattia Altini, Giovanni Luca Frassineti, Martina Vittoria Minguzzi

Get full text

Effectiveness of bevacizumab in first- and second-line treatment for metastatic colorectal cancer: ITACa randomized trial by Elisabetta Petracci, Emanuela Scarpi, Alessandro Passardi, Annibale Biggeri, Carlo Milandri, Stefano Vecchia, Fabio Gelsomino, Davide Tassinari, Stefano Tamberi, Ilaria Bernardini, Caterina Accettura, Giovanni Luca Frassineti, Dino Amadori, Oriana Nanni

Get full text

Chemoradiotherapy (Gemox Plus Helical Tomotherapy) for Unresectable Locally Advanced Pancreatic Cancer: A Phase II Study by Alessandro Passardi, Emanuela Scarpi, Elisa Neri, Elisabetta Parisi, Giulia Ghigi, Giorgio Ercolani, Andrea Gardini, Giuliano La Barba, Flavia Pagan, Andrea Casadei-Gardini, Martina Valgiusti, Fabio Ferroni, Giovanni Luca Frassineti, Antonino Romeo

Get full text

Erratum: Passardi, A. et al. Chemoradiotherapy (Gemox Plus Helical Tomotherapy) for Unresectable Locally Advanced Pancreatic Cancer: A Phase II Study. <i>Cancers</i> 2019, <i>11</i... by Alessandro Passardi, Emanuela Scarpi, Elisa Neri, Elisabetta Parisi, Giulia Ghigi, Giorgio Ercolani, Andrea Gardini, Giuliano La Barba, Flavia Pagan, Andrea Casadei-Gardini, Martina Valgiusti, Fabio Ferroni, Giovanni Luca Frassineti, Antonino Romeo

Get full text